Viruses, Serums, Toxins, and Analogous Products; Records and Reports

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
2388	Viruses, Serums, Toxins, and Analogous Products; Records and Reports	Migrated

ICR Details

OMB Control No: 0579-0209	ICR Reference No: 200508-0579-001
Status: Historical Inactive	Previous ICR Reference No: 200210-0579-003
Agency/Subagency: USDA/APHIS	Agency Tracking No:
Title: Viruses, Serums, Toxins, and Analogous Products; Records and Reports
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Comment filed on proposed rule and continue	Conclusion Date: 09/17/2005
	Date Received in OIRA: 08/17/2005
Terms of Clearance: In accordance with 5 CFR 1320, OMB is withholding approval for the collection at this time. Prior to publication of the final rule, the agency must provide to OMB all comments related to the new reporting comments and associated burden. They should also provide a summary of their responses and any changes made to the final rule as a result of these comments.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2006	09/30/2008	02/28/2006
Responses	1,000	0	1,000
Time Burden (Hours)	1,000	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: We are amending the Virus-Serum-Toxin Act regulations for records and reports. First, we are requiring veterinary biologics licensees are permittees to record and submit reports to APHIS concerning adverse events associated with the use of biological products that they produce or distribute. Second, we are requiring veterinary biologics licensees and permittees to report to APHIS the number of doses of each licensed product that they distribute. Third, we are allowing reports to be electronically submitted to APHIS.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Viruses, Serums, Toxins, and Analogous Products; Records and Reports

---

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/17/2005

---